Asia Pacific Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Devices Type (Manual IO Needles, Battery Powered Driver and Impact Driven Devices), By End User, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Intraosseous Infusion Devices Market would witness market growth of 6.7% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Intraosseous Infusion Devices Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $98.7 Million by 2031. The Japan market is registering a CAGR of 6.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.4% during (2024 - 2031).



Compact intraosseous infusion devices play a crucial role in providing timely and effective emergency medical care in remote or austere environments where access to traditional medical facilities is limited or non-existent. Their portability and lightweight render them highly suitable for utilization in expeditionary healthcare missions, wilderness medicine, disaster response, or situations where expeditious vascular access is critical for the survival of critically ailing or injured patients.

Furthermore, these devices of the most recent generation integrate sophisticated safety functionalities, including pressure monitoring, depth control mechanisms, and visual verification of needle insertion, in order to reduce the likelihood of complications and enhance the precision of intraosseous access.

The increasing incidence of cardiovascular diseases in India, in conjunction with the expansion of healthcare infrastructure and obstacles in conventional venous access, are driving the need for these devices as critical instruments for addressing urgent cardiovascular crises and enhancing patient results. As per the World Health Organization, India is responsible for one-fifth of the global deaths due to CVD, particularly among the younger population. By the Global Burden of Disease study findings, India has an age-standardized CVD death rate of 272 per 100,000 people, significantly higher than the global average of 235. Moreover, Australia's healthcare system is expanding its emergency and critical care services to meet the needs of its growing population and address the rising incidence of medical emergencies. As per the data from the Government of Australia, the country spent an estimated $241.3 billion on health goods and services in 2021-22 - an average of approximately $9,365 per person. The real growth (adjusted for inflation) in total health spending (recurrent and capital) was 6.0% more than in 2020-21. This was higher than the average yearly growth rate over the decade to 2021-22 (3.4%). Thus, the growing healthcare sector and increasing CVD cases in the Asia Pacific will propel the growth of the regional market.

Based on Devices Type, the market is segmented into Manual IO Needles, Battery Powered Driver and Impact Driven Devices. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Aero Healthcare AU Pty Ltd
• Teleflex Incorporated
• Becton, Dickinson and Company
• BIOPSYBELL S.R.L.
• Cook Medical, Inc.(Cook Group)
• The Seaberg Company Inc. (SAM Medical)
• Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
• Medax Srl
• PAVmed Inc.

Market Report Segmentation

By Devices Type

• Manual IO Needles
• Battery Powered Driver
• Impact Driven Devices

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific